Furthermore, EGCG has been reported to inhibit epidermal growth factor (EGF)-induced activation of the EGF-receptor (EGFR) [62], a frequently encountered aberrant oncogenic pathway in glioblastoma and many other cancers. The gene discussed is EGFR; the disease is glioblastoma.